TJSCF yields 7.70% · JNJ yields 2.13%● Live data
📍 TJSCF pulled ahead of the other in Year 1
Combined, TJSCF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TJSCF + JNJ for your $10,000?
Tianjin Development Holdings Limited, through its subsidiaries, supplies electricity, water, heat, and thermal power to industrial, commercial, and residential customers in the Tianjin Economic and Technological Development Area, the People's Republic of China. It operates through six segments: Utilities, Pharmaceutical, Hotel, Electrical and Mechanical, Port Services, and Elevators and Escalators. The company has an installed transmission capacity of approximately 946,000 kVA; daily water supply capacity of 425,000 tons; and steam transmission pipelines of approximately 462 kilometres, approximately 120 processing stations, and daily distribution capacity of approximately 30,000 tons. It also provides services in relation to construction of electricity supply network, application of technology related to new energy and renewable energy, and electricity construction and related technical services; and offers services in installation and maintenance of water pipes, and technical consultancy, as well as engages in the retail and wholesale of water pipes and related parts. In addition, the company is involved in the manufacture and sale of presses, and mechanical and hydroelectric equipment, as well as large scale pump units. Further, it operates Courtyard by Marriott Hong Kong, a 4-star hotel with 245 guest rooms; researches and develops medicine technology and products; manufactures and sells chemical drugs; designs, manufactures, and prints pharmaceutical packaging products, as well as sells other paper-based packaging materials; manufactures and sells elevators and escalators; operates financing leasing business; and provides port services. The company was incorporated in 1997 and is based in Central, Hong Kong. Tianjin Development Holdings Limited is a subsidiary of Tsinlien Group Company Limited.
Full TJSCF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.